Dr. Arnar Sigurðsson is a biochemist who specializes in bioactive compounds and natural products as our Principal Scientist. He has a background in systems biology and structural biology which complements Axelyf’s ongoing R&D programs.

Arnar completed his Ph.D in Biological Chemistry from the Technical University of Berlin in 2024 working in the field of Ribosomally synthesized and post-transitionally modified peptides. Arnar has published research from his studies as masters and Ph.D. candidate, including publications in Nature and Angewandte Chemie, and he is a versatile talent in biotech/pharmaceutical R&D and company building at Axelyf.